damn!.......
Monday March 5, 8:03 pm Eastern Time
Press Release
Large Scale Biology Corporation Media Advisory - Company Presentation on March 7 Postponed Due to Inclement Weather
VACAVILLE, Calif.--(BW HealthWire)--March 5, 2001--Large Scale Biology Corporation (NASDAQ: LSBC - news) announced today that it's postponed the Company's scientific briefing and webcast on the first version of its inventory of proteins in the human body, known as the Human Protein Index(TM) (HPI(TM)). The briefing was to be held on Wednesday, March 7, from 9:30 AM to 12:00 PM at the New York Academy of Sciences in New York City.
A severe winter storm in the Northeast has forced the postponement of the briefing and webcast; both will be rescheduled at a later date. All media and other individuals who have registered for the meeting and need further information may contact Dr. Kathy Jones, of Burns McClellan, at (212) 213-0006.
Large Scale Biology Corporation is an industry leader in identifying and characterizing proteins in all types of biological samples for the discovery and development of new and more effective disease diagnostics, therapeutics, vaccines and agricultural products. Large Scale Biology has pioneered the development and application of many of the tools that are now considered state-of-the-art in genomics and proteomics. Corporate offices and the Genomics and Antigenics divisions are headquartered in Vacaville, California; the Company's Proteomics subsidiary is located in Germantown, Maryland; and the Company's bioprocessing and manufacturing facilities are located in Owensboro, Kentucky. For more information about LSBC, visit the Company's website at www.lsbc.com.
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on our current plans, expectations, estimates, and projections and management's beliefs about our future performance. Words such as ``anticipates,'' ``expects,'' ``intends,'' ``plans,'' ``believes,'' ``seeks,'' ``estimates'' or variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties that are difficult to predict and which may cause our actual results and performance to differ materially from those expressed or forecasted in any such forward-looking statements. For a further list and description of such risks and uncertainties see the reports filed by Large Scale Biology Corporation with the Securities Exchange Commission. Unless required by law, Large Scale Biology Corporation undertakes no obligation to update publicly any forward-looking statements.
Contact:
Burns McClellan, New York Dr. Kathy Jones, 212/213-0006 |